Recent research has shown that PD-1 and PD-L1/PD-L2 pathway plays important roles in various cancers, including breast cancer, lung cancer, colorectal cancer, gastric cancer, bladder cancer, pancreatic cancer, prostate cancer, and DLBCL tumor. In this case, inhibitors targeting PD-1/PD-L1 have been reported for cancer therapy, and some of them are approved by FDA. Learn more: https://immune-checkpoint.creative-biolabs.com/pd-1-and-pd-l1-pd-l2-pathway.htm
comments (0)
Copyright 2019 © P-tweets Refunds